Most favored pricing and market check

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. I looked for most favored client pricing, a market check and a meet, credit or release remedy in Exhibit 2 Section 3 on page 22, Exhibit 7 Sections 7 through 10 on pages 45 to 47 and the termination provisions on pages 11 and 46. The only repricing mechanics in the text run in the Claim Administrator's favor: service charges may be changed on enrollment or benefit variances (page 22), benefit design changes can void addendum pricing and force renegotiation (page 45), and AWP methodology changes trigger automatic adjustment to restore the vendor's economic position (page 45). The Employer's only lever is a ninety day termination right at the end of a Guarantee Period or Fee Schedule Period (pages 11 and 46). Nothing gives the plan pricing at least as good as comparable clients or a right to test the market during the term, so the verdict is missing.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. I reviewed the entire Administrative Services Agreement, focusing on the fee terms on Pages 21 through 25 and the pharmacy pricing terms on Pages 45 through 47. The contract contains no most favored nation clause guaranteeing pricing at least as favorable as any comparable customer. Furthermore, it provides no mechanism for an annual market check with a meet, credit, or release remedy. Because neither protection appears in the produced text, this item is missing.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. I reviewed the pharmacy exhibit on pages 43 through 49, the general fee provisions on pages 21 and 22, and termination provisions on pages 11 and 46. None promises the city terms as favorable as those of a comparable client, automatically improves its rates, or gives it an annual market check with a meet, credit or release mechanism. The agreement permits service charge changes for several events instead. The missing PBM Fee Schedule Addendum could disclose actual guarantees and their time periods, but a most favored client commitment and market-check procedure are not addressed anywhere in the produced text. Their absence is classified as missing, rather than unclear solely because the attachment is absent.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. I looked in Exhibit 2 service charge provisions on Pages 21 through 25, in Exhibit 7 pricing and termination on Pages 45 and 46, and in the inter plan fee section on Page 40. Nothing says the Employer automatically receives pricing at least as good as any comparable client. Nothing gives the Employer an annual market check with a meet, credit, or release remedy. Page 40 lets the Employer terminate if inter plan arrangement fees change, after notice, and describes that path as without penalty. That is a narrow fee change exit for BlueCard and related fees, not a market check of pharmacy pricing. Page 22 lets Claim Administrator change service charges when projections, census, or producer and broker fees become outdated. That is a vendor repricing right, not a most favored pricing right for the Employer. The model contract requires both automatic comparable client pricing and an annual market check remedy. Neither is addressed, and neither is placed in the omitted fee schedule by name. This item is missing.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. The model term gives the plan pricing at least as good as any comparable client plus an annual market check with a meet, credit or release remedy. I searched the compensation provisions in Exhibit 2 on pages 21 through 24, the fee change provisions on pages 22 and 40, the AWP benchmark provisions on page 45, and the termination provisions on pages 11, 24, 25 and 46. What exists instead are repricing triggers running in the vendor's favor: section 3.3 of Exhibit 2 on page 22 lets the Claim Administrator change service charges on enrollment variance, benefit changes, or government cost increases, and page 40 lets Inter-Plan fees change on notice with deemed approval. No most favored client clause and no market check mechanism appears anywhere in the 55 pages, so this term is not addressed.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.